[go: up one dir, main page]

ITRM960171A0 - - Google Patents

Info

Publication number
ITRM960171A0
ITRM960171A0 ITRM960171A ITRM960171A ITRM960171A0 IT RM960171 A0 ITRM960171 A0 IT RM960171A0 IT RM960171 A ITRM960171 A IT RM960171A IT RM960171 A ITRM960171 A IT RM960171A IT RM960171 A0 ITRM960171 A0 IT RM960171A0
Authority
IT
Italy
Application number
ITRM960171A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITRM960171A0 publication Critical patent/ITRM960171A0/it
Priority to IT96RM000171A priority Critical patent/IT1283951B1/it
Priority to TW086102934A priority patent/TW513304B/zh
Priority to JP53332497A priority patent/JP2001503731A/ja
Priority to CA002248879A priority patent/CA2248879A1/en
Priority to US09/147,034 priority patent/US6037372A/en
Priority to PCT/IT1997/000056 priority patent/WO1997034596A1/en
Priority to KR10-1998-0707309A priority patent/KR100481188B1/ko
Priority to EP97907268A priority patent/EP0888113A1/en
Priority to ZA9702219A priority patent/ZA972219B/xx
Publication of ITRM960171A1 publication Critical patent/ITRM960171A1/it
Application granted granted Critical
Publication of IT1283951B1 publication Critical patent/IT1283951B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT96RM000171A 1996-03-15 1996-03-15 Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di IT1283951B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT96RM000171A IT1283951B1 (it) 1996-03-15 1996-03-15 Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
TW086102934A TW513304B (en) 1996-03-15 1997-03-10 Use of an alkanoyl L-carnitine or a pharmacologically acceptable salt thereof for the therapeutic treatment or prophylaxis of glutamate-mediated disturbances or diseases
US09/147,034 US6037372A (en) 1996-03-15 1997-03-12 Use of an alkanoyl-L-carnitine for the treatment of glutamate mediated diseases
CA002248879A CA2248879A1 (en) 1996-03-15 1997-03-12 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases
JP53332497A JP2001503731A (ja) 1996-03-15 1997-03-12 グルタメート仲介疾患の処置のためアルカノイル―ｌ―カルニチンの使用
PCT/IT1997/000056 WO1997034596A1 (en) 1996-03-15 1997-03-12 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases
KR10-1998-0707309A KR100481188B1 (ko) 1996-03-15 1997-03-12 글루타민산염관련질환치료용알카노일-l-카르니틴의용도
EP97907268A EP0888113A1 (en) 1996-03-15 1997-03-12 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases
ZA9702219A ZA972219B (en) 1996-03-15 1997-03-14 Alkanoyl L-carnitine composition against glutamate-mediated conditions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000171A IT1283951B1 (it) 1996-03-15 1996-03-15 Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di

Publications (3)

Publication Number Publication Date
ITRM960171A0 true ITRM960171A0 (it) 1996-03-15
ITRM960171A1 ITRM960171A1 (it) 1997-09-15
IT1283951B1 IT1283951B1 (it) 1998-05-07

Family

ID=11403995

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000171A IT1283951B1 (it) 1996-03-15 1996-03-15 Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di

Country Status (9)

Country Link
US (1) US6037372A (it)
EP (1) EP0888113A1 (it)
JP (1) JP2001503731A (it)
KR (1) KR100481188B1 (it)
CA (1) CA2248879A1 (it)
IT (1) IT1283951B1 (it)
TW (1) TW513304B (it)
WO (1) WO1997034596A1 (it)
ZA (1) ZA972219B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
US6589994B1 (en) * 1996-08-30 2003-07-08 Nps Pharmaceuticals, Inc. Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
IT1299161B1 (it) * 1998-04-17 2000-02-29 Sigma Tau Healthscience Spa Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
PT1100589E (pt) * 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
IT1302289B1 (it) * 1998-09-30 2000-09-05 Univ Catania Composizioni farmaceutiche ad attivita' antineoplastica
CA2350071A1 (en) * 1998-11-11 2000-05-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis
WO2000030637A1 (it) * 1998-11-26 2000-06-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine acid fumarate and of its alkanoyl derivatives for the preparation of a composition useful for the prevention and treatment of ischaemia
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
JP2006347935A (ja) * 2005-06-15 2006-12-28 Masanori Ogata 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
EA201170732A1 (ru) * 2008-12-01 2011-12-30 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Применение алканоил l-карнитина в комбинации с химиотерапевтическими средствами для лечения новообразований
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2586438A1 (en) * 2011-10-28 2013-05-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine
CN114522158B (zh) * 2022-01-21 2023-06-27 武汉大学 用于制备治疗肝癌药物的代谢物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
AU6922994A (en) * 1993-06-21 1995-01-17 Bernardini, Attilio Use of acylcarnitin to treat illnesses caused by aids

Also Published As

Publication number Publication date
US6037372A (en) 2000-03-14
IT1283951B1 (it) 1998-05-07
KR20000064614A (ko) 2000-11-06
JP2001503731A (ja) 2001-03-21
EP0888113A1 (en) 1999-01-07
ZA972219B (en) 1997-09-17
ITRM960171A1 (it) 1997-09-15
KR100481188B1 (ko) 2005-07-07
WO1997034596A1 (en) 1997-09-25
CA2248879A1 (en) 1997-09-25
TW513304B (en) 2002-12-11

Similar Documents

Publication Publication Date Title
AR026661A2 (it)
BRPI9713914B8 (it)
BR7600721U (it)
BR7601346U (it)
BR9603859A (it)
CN3042589S (it)
CN3043416S (it)
CN3039060S (it)
CN3039213S (it)
CN3040024S (it)
CN3040367S (it)
CN3040543S (it)
CN3040550S (it)
CN3040805S (it)
CN3041115S (it)
CN3041207S (it)
CN3045806S (it)
CN3041383S (it)
CN3042193S (it)
CN3042289S (it)
CN3042424S (it)
CN3045530S (it)
CN3043305S (it)
CN3043413S (it)
CN3043414S (it)

Legal Events

Date Code Title Description
0001 Granted